Mr Fangbin Hao | Moyamoya disease | Best Researcher Award

Attending doctor, Department of Neurosurgery, Chinese PLA General Hospital, China

Dr. Fangbin Hao 👨‍⚕️ is a seasoned and accomplished medical professional specializing in Neurosurgery, with a keen focus on Moyamoya disease. Currently serving as an Attending Doctor in the Department of Neurosurgery at the esteemed Chinese PLA General Hospital, Dr. Hao boasts over 11 years of dedicated contributions to the field.

With a Medical Doctor qualification, he has channeled his expertise towards advancing the understanding and treatment of neurological disorders, placing special emphasis on Moyamoya disease—a condition affecting the brain’s blood vessels.

Dr. Hao embarked on his career journey in 2019 at the Chinese PLA General Hospital, where he has played a pivotal role in delivering exceptional healthcare and making significant contributions to Neurosurgery research. His unwavering commitment to patient care and research is palpable through his continuous efforts to stay at the forefront of medical advancements.

For any professional inquiries or consultations, feel free to reach out to Dr. Fangbin Hao at 📞 15313508553 or ✉️ 632072284@qq.com.

Experience

Dr. Fangbin Hao stands out as a highly skilled neurosurgeon with a distinct focus on Moyamoya disease. In his role as an Attending Neurosurgeon, Dr. Hao has made noteworthy contributions to the field, evident in the publication of 18 SCI-indexed papers. His research primarily explores surgical outcomes, risk factors, and diagnostic advancements related to Moyamoya disease, with a special emphasis on the application of high-resolution MRI technology.

Dr. Hao’s commitment to Moyamoya disease research is exemplary, reflecting a dedication to both clinical practice and academic excellence. Through his extensive body of work, he not only enhances our understanding of the disease but also contributes valuable insights that have a lasting impact on the broader field of neurosurgery.

Contribution

Throughout my professional journey, my commitment to research, innovation, and knowledge extension has been central to my contributions. Specializing in Moyamoya disease, 🧠 my work encompasses 18 SCI-indexed publications, delving into various aspects such as long-term outcomes, collateral circulation, risk factors, and diagnostic advancements using high-resolution MRI. 📊

Beyond publications, I actively engage in collaborative initiatives nationally and internationally, fostering joint projects and contributing to the organization of research conferences and workshops. 🌐 My involvement in consultancy and industry-sponsored projects reflects my dedication to translating research into practical applications, aiming to advance clinical practices and patient care. 💡

My multifaceted approach to Moyamoya disease research reflects a commitment to impactful contributions within neurosurgery. As I navigate the realms of research and development, my goal is to bridge academia and practical applications, promoting continuous innovation and meaningful contributions to the scientific community at large. 🚀

Research Focus

The research conducted by Dr. Hao and his team focuses on the high-resolution magnetic resonance imaging (MRI) vessel wall enhancement in Moyamoya disease, a rare cerebrovascular disorder. 🧠 Their study explores risk factors and clinical outcomes associated with this enhancement, providing valuable insights into the diagnosis and prognosis of Moyamoya disease.

In parallel investigations, the team delves into proteomic and metabolomic characterizations of Moyamoya disease patient sera, offering a comprehensive understanding of the biochemical aspects of the condition. 🧪 Additionally, their work evaluates the diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated Moyamoya vasculopathy from Moyamoya disease.

Publications Top notes

1. High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes”
   • Authors: Hao, F., Han, C., Lu, M., … Cai, J., Duan, L.
   • Journal: European Radiology (2024)
   • Link
2. “Proteomic and metabolomic characterizations of moyamoya disease patient sera”
   • Authors: Guo, Q., Wang, Q.-N., Li, J., … Bao, X., Duan, L.
   • Journal: Brain and Behavior (2023, 13(12), e3328)
   • Link
3. “The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated moyamoya vasculopathy from moyamoya disease”
   • Authors: Liu, S., Lu, M., Gao, X., … Zhang, H., Cai, J.
   • Journal: European Radiology (2023, 33(10), pp. 6918–6926)
   • Citations: 3
   • Link
4. “Surgical outcomes following encephaloduroarteriosynangiosis in moyamoya disease associated with hyperhomocysteinemia”
   • Authors: Gao, G., Hao, F.-B., Wang, Q.-N., … Han, C., Duan, L.
   • Journal: Brain and Behavior (2023, 13(8), e3093)
   • Link
5. “Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging”
   • Authors: Lu, M., Zhang, H., Liu, S., … Han, C., Cai, J.
   • Journal: Journal of Neurology, Neurosurgery and Psychiatry (2023, 94(7), pp. 567–574)
   • Citations: 3
   • Link
6. “Association of cognitive function and hypoperfusion in Moyamoya disease patients without stroke”
   • Authors: Shen, X.-X., Zhang, H.-D., Fu, H.-G., … Duan, L., Han, C.
   • Journal: Journal of Cerebral Blood Flow and Metabolism (2023, 43(4), pp. 542–551)
   • Citations: 1
   • Link
7. “Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya disease”
   • Authors: Lu, M., Zhang, H., Liu, D., … Han, C., Cai, J.
   • Journal: European Radiology (2023, 33(4), pp. 2489–2499)
   • Citations: 4
   • Link
8. “Metabolomic analysis of human plasma sample after exposed to high altitude and return to sea level”
   • Authors: Gao, J., Zhao, M., Cheng, X., … Han, C., Zhu, L.
   • Journal: PLoS ONE (2023, 18(3 March), e0282301)
   • Citations: 1
   • Link